Abstract The purpose of this study was to determine the microbiological profile of diabetic foot infections (DFIs) and assess the antibiotic susceptibility of the causative agents. Data were obtained from a retrospective analysis of DFI samples collected from June 2007 to July 2008. Specimens were cultured using optimal aerobic and anaerobic microbiological techniques, and antibiotic susceptibility testing was performed according to the methods recommended by the Clinical and Laboratory Standards Institute (CLSI). Extended-spectrum ␤-lactamase (ESBL) production was measured using the double disk synergy test and the ESBL Etest. A total of 440 patients were diagnosed with DFIs during this period, and a total of 777 pathogens were isolated from these patients with an average of 1.8 pathogens per lesion. We isolated more Gram-negative pathogens (51.2%) than Gram-positive pathogens (32.3%) or anaerobes (15.3%). Polymicrobial infection was identified in 75% of the patients. The predominant organisms isolated were members of the Enterobacteriaceae family (28.5%), Pseudomonas aeruginosa (17.4%), Staphylococcus aureus (11.8%), methicillin-resistant S. aureus (7.7%), anaerobic Gram-negative organisms (10.8%), and Enterococcus spp. (7%). Vancomycin was the most effective treatment for Gram-positive bacteria, and imipenem, piperacillin-tazobactam and amikacin were the most effective treatments for the Gram-negative bacteria. In conclusion, DFI is common among diabetic patients in Kuwait, and most of the cases evaluated in this study displayed polymicrobial etiology. The majority of isolates were multi-drug resistant. The data gathered in this study will be beneficial for future determinations of empirical therapy policies for the management of DFIs.
Introduction
Diabetes mellitus (DM) is a very serious disease and a major global cause of morbidity and mortality. The prevalence of DM in Kuwait is approximately 33.2% of the general population [1] . It is well known that patients with poorly controlled DM are at risk of developing diabetic complications such as pedal ulcers with or without gangrene, retinopathy, neuropathy and macrovascular complications [2] . Approximately 15% of patients with DM develop foot ulcers, which eventually progress to osteomyelitis [3] . Diabetic foot infections (DFIs) are common, complex and costly complications of DM. In addition to causing severe morbidities, they account for the largest number of diabetesrelated hospital inpatient days and are the most common proximate, nontraumatic cause of amputations [4, 5] . Several studies have investigated the relationship between the types of infections and the number and types of organisms recovered from wound infections. These studies found that most mild infections are monomicrobial and are caused by aerobic Gram-positive cocci such as Staphylococcus aureus and Streptococcus spp. Further, they found that most severe infections are usually polymicrobial and caused by aerobic Gram-positive cocci, Gram-negative bacilli (e.g., Pseudomonas spp., Escherichia coli, Klebsiella spp. and Proteus spp.) and anaerobes [6] .
Optimal management of DFIs can reduce the incidence of infection-related morbidities, the need for and duration of hospitalization, and the incidence of major limb amputation. Early identification of lesions, prompt initiation of appropriate antibiotic therapy, aggressive surgical debridement of necrotic soft tissue and bone, and modification of host factors are all equally important for a successful clinical outcome [7] . Because many DFIs are true emergencies, antibiotic therapy must be started immediately to improve the chances of limb salvage. This study was undertaken to study the bacteriology of diabetic foot ulcers and to assess the in vitro antimicrobial susceptibility of the causative pathogens in Al-Amiri Hospital, a 400-bed hospital located in downtown Kuwait. This hospital is a general tertiary care center with a very busy diabetic clinic and is the primary center for diabetic foot infection referrals.
Materials and methods
All patients with DFIs that presented clinically infected wounds or ulcers and received inpatient or outpatient treatment at Al Amiri Hospital between June 1, 2007 and July 31, 2008 were included in this study. Patients who had received systemic antibiotic therapy for more than 24 h within the previous 72 h were excluded from the study. Each patient was included only once in this study. Patients were clinically assessed and their foot lesions were graded according to the diabetic foot infection severity classification system of the Infectious Diseases Society of America (IDSA) [7] . Infected wounds were classified as mild, moderate, or severe based on the size (especially of any cellulitis) and depth (or level of tissue involved) of the infection and the presence of systemic manifestations of infection or metabolic instability.
Laboratory and hospital records of the diabetic patients treated in our hospital between June 2007 and July 2008 were carefully reviewed. The specimen collection techniques excluded superficial or colonizing organisms, and only clinically infected wounds were included. Only non-duplicate isolates were included in the study. Cultures of the specimens were obtained at the time of admission after the surface of the wound had been washed vigorously with saline, followed by debridement of the superficial tissue from the exudates to avoid isolation of colonizing (rather than pathogenic) flora. Specimens were collected by curettage of the base of the ulcer after debridement, needle aspiration of the abscess material and aspiration of material through the infected skin and deep tissues. All specimens were Gram-stained, and the bacteria were isolated by inoculation of specimens on a set of selective and non-selective media such as blood agar (BA; Oxoid, Basingstoke, UK), MacConkey agar (Oxoid), chocolate agar and 5% (v/v) BA supplemented with vitamin K 1 (1 g/ml), haemin (5 g/ml) and gentamicin (75 g/ml) (GBA). All of the inoculated plates were incubated under the appropriate atmospheric conditions for 24-48 h. Isolated organisms were identified by conventional microbiological methods: API 20E for Gram-negative aerobes, API Staph for staphylococci, API 20 Strep for streptococci and enterococci and API 20A (bioMérieux, Marcy l'Etoile, France) and GLC (Chromopak, CP9001, The Netherlands) for anaerobes.
Antimicrobial susceptibility testing
The antimicrobial susceptibility of the bacterial isolates was determined using the disk diffusion method, according to the guidelines of the CLSI [8] . Briefly, isolated colonies were suspended in sterile distilled water and matched to the 0.5 McFarland standard. A sterile cotton wool swab was dipped into the inoculums and used to streak Mueller-Hinton agar plates (Oxoid, Basingstoke, Hampshire, UK) for Gram-negative bacilli, staphylococci and enterococci and Mueller-Hinton agar supplemented with 5% horse blood for streptococci. Antibiotic discs were then applied to the surface of the plates. The inoculated agar plates were incubated at 35-37 • C for 18-20 h. After incubation, the diameter of the zone of inhibition was interpreted according to the criteria recommended by the CLSI [8] . S. aureus was tested for methicillin resistance using a 1-g oxacillin disc. Reference strains of E. coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 27853) were used as controls for Gram-negative bacteria and were included in all daily tests. S. aureus (ATCC 25923) and E. faecalis (ATCC 929212) were used as Gram-positive control strains.
Detection of extended-spectrum ␤-lactamase
Gram-negative bacilli were tested for ESBL production using the double disc diffusion test (DDT), followed by confirmation with the ESBL Etest (AB Biodisk, Solna, Sweden), as recommended by the CLSI [8] . The DDT was performed using a standard disk diffusion assay on Mueller-Hinton agar (Becton Dickinson). Disks containing aztreonam, ceftazidime, cefepime, ceftriaxone or cefotaxime (30 g each) were placed at variable distances (20-30 mm from center to center, depending on the species) around a disk containing amoxicillin (20 g) and clavulanic acid (CA) (10 g). Enhancement of the inhibition zone toward the amoxicillin-plus-CA disk was considered suggestive of ESBL production. The presence of ESBL was confirmed using two different Etest strips containing ceftazidime and cefotaxime, with or without clavulanate, respectively. Isolates of E. coli and Klebsiella spp. were considered ESBL producers when the ratio of the ceftazidime MIC and the ceftazidime clavulanic acid MIC or ratio of the cefotaxime MIC and the cefotaxime clavulanic acid MIC was equal to or greater than 8. Additionally, a strain was considered an ESBL producer if a phantom zone or a deformation of the ceftazidime and cefotaxime zone was observed independent of the ratios or MICs [8] .
Results
A total of 440 patients with DFIs were included in this study. The data from all of the patients are shown in Table 1 . Out of the 440 patients, 288 (65%) were male and 152 (35%) were female, a male-tofemale ratio of 1.89:1. The ages of the patients ranged from 37 to 91 years, with a mean age of 56.7 years. Among the total patient population, 432 (98.2%) presented with type 2 diabetes mellitus, whereas only 8 (1.8%) patients had type 1 diabetes mellitus. The majority of patients were Kuwaiti nationals (82.9%). A total of 777 pathogens were isolated from the 440 patients, with an average of 1.8 organisms per lesion. The specimens containing clinically significant pathogens included wound swabs (388; 88.2%), tissue (34; 7.7%), pus (13; 3%) and bone (5; 1.1%). The number of patients graded based on foot lesions and the numbers of bacterial isolates are shown in Table 2 . The maximum number of organisms was isolated from moderate foot wounds (n = 362). A variety of organisms were isolated from the DFIs, as presented in Analysis of the infected patients revealed that 330 (75%) of the 440 patients had polymicrobial infections. Of these, the most common isolates were S. aureus in 99 (30%) patients, followed by P. aeruginosa in 110 (33%) patients and anaerobes in 110 (33%) patients. Monomicrobial etiology was observed in 110 patients. S. aureus was the most common organism cultured from monomicrobial samples and was cultured from 45 (41%) patients. Pseudomonas spp. was the second most common bacteria cultured from monomicrobial samples and was cultured from 25 (22.7%) patients. Anaerobes were cultured from 9 (8%) patients and Enterococcus spp. were cultured from 7 (6%) patients. The majority (73%) of these patients were infected with aerobes only. Infection with anaerobes exclusively was only observed in nine patients. The antimicrobial susceptibility pattern of the Gram-positive cocci is shown in Table 4 . Of the 144 S. aureus isolates, 41.6%, 1.4% and 36% were resistant to methicillin, rifampicin and fusidic acid, respectively. All of the S. aureus isolates were sensitive to vancomycin. All of the Enterococcus spp. were susceptible to vancomycin, but 2% and 17% were resistant to ampicillin and penicillin, respectively. All isolates of S. agalactiae were susceptible to penicillin, ampicillin and vancomycin, but 14.7% were resistant to clindamycin. The antibiotic resistance pattern of the Gram-negative bacilli is shown in Table 5 . Imipenem, amikacin and piperacillin-tazobactam were the most active antimicrobial agents tested against all of the isolates. Between 23% and 30%, and 13% and 70% of the Gram-negative isolates, were resistant to amoxicillin-clavulanic acid and ciprofloxacin, respectively. The antibiotic resistance pattern of isolated anaerobes is shown in Table 6 . Metronidazole, amoxicillin-clavulanic acid and piperacillin-tazobactam displayed excellent activity against all anaerobes; none of the anaerobes were resistant to these antibiotics. However, 29% of the anaerobic streptococci and 68% of the Table 5 Antimicrobial resistance pattern of Gram-negative bacilli from the infected foot ulcers of diabetic patients (n = 440).
Antimicrobial agents
Gram-negative organisms (% resistant) Amikacin  11  8  0  0  0  0  3  7  Amoxicillin clavulanic acid  --13  28  11  30  13  28  Ampicillin  --21  45  36  100  22  48  Cefotaxime  --0  0  5  14  5  11  Ceftazidime  16  12  ------Cefuroxime  --6  13  6  17  12  26  Ciprofloxacin  28  21  6  13  10  28  33  72  Gentamicin  16  12  11  23  6  17  11  24  Imipenem  13  10  0  0  0  0  3  7  Piperacillin  17  13  10  21  27  75  21  46  Piperacillin-tazobactam  10  7  0  0  3  8  5  11  Sulphonamides Trimethoprim  --17  36  ----Table 6 Antimicrobial susceptibility pattern of anaerobic bacterial isolates from the infected foot ulcers of diabetic patients (n = 440).
Antimicrobial agents Proportion susceptible (%) Anaerobic Streptococci
Bacteriodes species
Clostridium species
Fusobacterium species -11  100  Ampicillin/CA  18  100  84  100  2  100  4  100  11  100  Erythromycin  18  100  25  30  ----8  73  Cefoxitin  18  100  84  100  2  100  ----Clindamycin  12  67  27  32  ----9 
B. fragilis were resistant to clindamycin. Approximately 11% and 14% of E. coli and K. pneumoniae were ESBL producers, respectively. All of the ESBLproducing isolates were susceptible to imipenem and amikacin and over 92% were susceptible to piperacillin-tazobactam.
Discussion
DFIs are a significant and growing problem in Kuwait because of the high prevalence of DM in the Kuwaiti population; the most recent estimate placed DM prevalence at 33.2% of the general populace [1] . This study highlights the following salient points: the etiological agents of DFIs are mostly polymicrobial and contain a mix of Gram-positive and Gram-negative bacteria, the contribution of anaerobes to the infection is about 0.25 anaerobic bacteria per culture-positive specimen and most of the etiological agents are multiresistant. Anaerobes, when present in DFIs, are almost always isolated from cultures that also contain aerobes. In this study, even though polymicrobial infections were common, the isolation rate of anaerobes was lower than expected, particularly when compared with the previous report by Goldstein et al. [9] . This finding may be due to the use of suboptimal collection or transport methods or because the appropriate medium, which is selective for Gram-positive anaerobes, was not used. Although previous studies have shown that Gram-positive aerobes are the predominant pathogens in DFIs [10] . Gram-negative bacteria were the most frequently isolated pathogens from our patients. Therefore, the major infective organisms in diabetic foot ulcers in our patients differ from those found in previous studies. Our finding that S. aureus is the most common single pathogen is concordant with the majority of studies that also noted a high frequency of S. aureus in foot infections of diabetic patients [7, 11, 12] . However, its prevalence in this report is much lower than that found in earlier reports. Goldstein et al. [12] and Kajetan et al. [13] found 76% and 78% prevalence of S. aureus in their studies, respectively. This difference may be explained by the fact that the majority of our patients had severe DFIs, which are usually polymicrobial in nature, as opposed to the milder forms of DFIs, which are more commonly associated with aerobic Gram-positive cocci such as S. aureus. MRSA has been a pathogen of concern in patients with DFIs for almost two decades. More recently, the emergence of community-acquired MRSA has been noted [14] . In our study, the isolation rate of MRSA was almost four-fold higher than MRSA isolation rates in previous studies performed in Kuwait and Saudi Arabia [13, 15] . This change may be attributable to the absence of strict guidelines for prescription of antibiotics, the lack of adherence to infection control measures in the hospital setting and an increased prevalence of MRSA in the community. Should this trend accelerate, it may affect empirical antimicrobial therapy.
Streptococci were cultured from approximately one quarter of our patients, and a large percentage of the isolated streptococci were S. agalactiae. This finding is hardly surprising because S. agalactiae is a common DFI pathogen and has been previously identified by other studies [9, 10] . Although enterococci are considered commensal and display low virulence, except in compromised patients such as diabetics in whom they can act as opportunistic pathogens, a relatively high proportion of our patients' DFIs were caused by other organisms, which confirms similar findings previously reported by other investigators [9] .
The relatively high prevalence of P. aeruginosa in this study may be due to previous antimicrobial use, lengthy hospitalization, chronic wounds and surgical procedures, which are all characteristic of patients with this type of infection in our hospital. We also noted a relatively high proportion of the Klebsiella spp. and E. coli isolates that were positive for ESBLs. Compared to other studies conducted in Kuwait and Saudi Arabia, we found that the prevalence of ESBL-producing Klebsiella spp. and E. coli was higher in our population of patients with DFIs [13, 15] . Thus, this study emphasizes the importance of routine screening for ESBL-producing Enterobacteriaceae in clinical laboratories.
Imipenem, amikacin and piperacillintazobactam were the most effective antimicrobial agents against aerobic Gram-negative bacteria, while vancomycin and metronidazole were the most active antimicrobial agents against aerobic Gram-positive cocci and anaerobes, respectively. Our findings demonstrate the importance of careful selection of antimicrobial therapy based on culture findings and the antimicrobial sensitivity patterns of the isolates. From our results, it is obvious that ciprofloxacin cannot be recommended for use as an empirical therapy in DFIs because the drug was inactive against most strains of pathogens found in these infections. For severe infections and more-extensive chronic moderate infections it is safest to initiate therapy with broad-spectrum agents such as the carbapenems or piperacillin-tazobactam. Definitive therapy can then be based on culture results, the susceptibility data and the clinical response to the empirical regimen. It cannot be over-emphasized that awareness of the causative organisms in diabetic foot infections and their antimicrobial susceptibility pattern is essential for the implementation of appropriate antimicrobial therapy.
In conclusion, diabetic foot infections in our patients were commonly associated with polymicrobial etiology; S. aureus and P. aeruginosa were the most common single agents. The proportion of anaerobic organisms was low. The antimicrobial susceptibility data suggest that imipenem or piperacillin-tazobactam and vancomycin may be appropriate agents for empirical coverage. Additionally, we encourage clinicians to collect proper post-debridement specimens for culture and urge clinical microbiology laboratories to report at least the genus of all organisms recovered from such specimens.
